← Search & browse all drugs

ferric (59Fe) citrate

V09XX04

Forms & Strengths

Diagnostic solution / Radiopharmaceutical
Contains radioactive iron-59 for clinical diagnostic use

Adult Dosing

Administered as a diagnostic tracer dose for specific iron metabolism studies
Exact dosage determined by specialized nuclear medicine protocols and institutional guidelines

Pediatric Dosing

Safety and efficacy in pediatric patients not formally established
Use restricted to specialized pediatric nuclear medicine centers under strict clinical protocols

Indications

Investigation of iron absorption, turnover, and utilization
Evaluation of disorders of iron metabolism using radioactive tracer techniques

Mechanism of Action

Utilizes the radioactive isotope iron-59 (59Fe) to trace physiological iron pathways
Incorporated into normal iron transport, storage, and erythropoiesis to measure kinetic parameters via radioactivity detection

Contraindications

Hypersensitivity to iron preparations or any component of the formulation
Pregnancy and lactation (unless diagnostic benefits outweigh significant radiation risks)

Adverse Reactions

Rare hypersensitivity or anaphylactoid reactions associated with parenteral iron administration
Radiation exposure associated with radioisotope administration

Drug Interactions

Concurrent administration of stable iron supplements may alter tracer kinetics and uptake
Chelating agents can interfere with the distribution and excretion of the radiolabeled iron

Curated Content: Needs Vetting Before Put to Clinical Use